SCHEMBL7708464

SCHEMBL7708464

c1ccc(Cc2cnc(N3CCOCC3)nc2N2CCOCC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.54
ALDH1A1 P00352 6/20 0.53
HPGD P15428 3/20 0.51
ACHE P22303 2/20 0.50
GAA P10253 2/20 0.50
MAPK1 P28482 1/20 0.50
GLA P06280 1/20 0.50
CYP11B2 P19099 1/20 0.49
TSHR P16473 4/20 0.49
HTT P42858 1/20 0.49
CYP1A2 P05177 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CLK4 Q9HAZ1 1/20 0.48
MTOR P42345 2/20 0.48
HTR2C P28335 1/20 0.47
HTR2B P41595 1/20 0.47
HSD17B10 Q99714 2/20 0.47
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7711748 0.88 ALDH1A1 (0.54) KDM4EALDH1A1HPGDACHEGAA
SCHEMBL7714543 0.85 PIK3CA (0.55) ALDH1A1HPGDGAAMAPK1TSHR
SCHEMBL7712401 0.85 HPGD (0.50) KDM4EALDH1A1HPGDACHEGAA
SCHEMBL7708441 0.84 TSHR (0.57) ALDH1A1HPGDACHEGAAMAPK1
SCHEMBL7708550 0.76 CYP1A2 (0.53) KDM4EALDH1A1HPGDACHEMAPK1
SCHEMBL1123892 0.76 MAPT (0.54) KDM4EALDH1A1HPGDGAAMAPK1
SCHEMBL1123750 0.76 MAPT (0.54) KDM4EALDH1A1HPGDGAAMAPK1
SCHEMBL7708477 0.74 MGMT (0.48) ALDH1A1HPGDACHEGAAMAPK1
SCHEMBL7708590 0.74 MAPT (0.47) KDM4EALDH1A1HPGDACHEGAA
SCHEMBL7711799 0.74 OGA (0.47) KDM4EALDH1A1HPGDACHEGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP claimed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO claimed
US-6440965-B1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system KRENITSKY PHARMACEUTICALS, INC. 2002-08-27 US disclosed
EP-1025091-A1 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM Krenitsky Pharmaceuticals, Inc. (US) 2000-08-09 EP disclosed
WO-1999019305-A2 SUBSTITUTED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE OR NEUROLOGICAL DISORDERS OF THE CENTRAL NERVOUS SYSTEM KRENITSKY PHARMACEUTICALS INC. (US) 1999-04-22 WO disclosed